State of Wisconsin Investment Board
JNCE

State of Wisconsin Investment Board’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

State of Wisconsin Investment Board’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,900
Closed -$169K – 2915
2022
Q1 		$169K Sell
24,900
-11,500
-32% -$82K ﹤0.01% 2197
2021
Q4 		$304K Sell
36,400
-1,600
-4% -$13.2K ﹤0.01% 1952
2021
Q3 		$282K Buy
38,000
+1,300
+4% +$8.05K ﹤0.01% 1982
2021
Q2 		$250K Sell
36,700
-15,700
-30% -$130K ﹤0.01% 2009
2021
Q1 		$538K Sell
52,400
-17,500
-25% -$192K ﹤0.01% 1575
2020
Q4 		$489K Buy
69,900
+29,500
+73% +$230K ﹤0.01% 1551
2020
Q3 		$330K Buy
40,400
+25,700
+175% +$159K ﹤0.01% 1688
2020
Q2 		$101K Sell
14,700
-7,900
-35% -$42.6K ﹤0.01% 1636
2020
Q1 		$107K Buy
+22,600
New +$130K ﹤0.01% 1620
2019
Q3 		– Sell
-21,600
Closed -$107K – 1596
2019
Q2 		$107K Buy
21,600
+500
+2% +$2.65K ﹤0.01% 1518
2019
Q1 		$131K Buy
21,100
+4,800
+29% +$23.2K ﹤0.01% 1493
2018
Q4 		$55K Buy
+16,300
New +$76.1K ﹤0.01% 1518

Other funds holding JNCE

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

State of Wisconsin Investment Board's JNCE Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2022, closing a stake of 24,900 shares — an estimated $169K sold.

State of Wisconsin Investment Board first reported a position in JNCE in Q4 2018 and held it in 12 quarters. The position peaked at $538K in Q1 2021. 102 funds tracked by Wall St. Rank hold JNCE as of Q2 2022.

  • State of Wisconsin Investment Board reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 24,900 Jounce Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $169K.
  • State of Wisconsin Investment Board first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2018 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Jounce Therapeutics, Inc. Common Stock position peaked at $538K in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.